3 Credit Bureaus, 11 Debt Collectors, and Care Credit: 41% of 2024 Medical CFPB Complaints

The problem: When the medical-debt story gets covered, the named entities are almost always hospital systems, private equity owners, or insurance companies. The companies actually doing the collection — the firms whose names show up on the dunning letters and the credit-report tradelines — almost never make the headline. The 2024 CFPB Consumer Complaint Database flips that hierarchy. The most-complained-about companies in medical-related US consumer complaints aren't hospitals at all. They're three credit bureaus, eleven specialised debt collectors, and one consumer bank running a deferred-interest medical credit card.

This post is a documentary audit of the CFPB Consumer Complaint Database for calendar year 2024, filtered to complaints whose narrative or issue text references medical concerns. The data is public. The named-defendant leaderboard is publishable, citable, and — for healthcare-finance press — sharper than the framing usually allows.

What this is: A 2024 audit of CFPB consumer complaints filtered for medical-related issues, aggregated by named company. 10,987 complaints in the universe; the top 15 named defendants are listed in full below.

Why it matters: Coverage of the US medical-debt crisis routinely names hospitals, insurers, and PE-owned ER staffing firms. The named-defendant ranking on consumer-side friction looks completely different. Three credit bureaus, eleven specialised debt collectors, and Synchrony's Care Credit account for 41% of the friction; hospitals don't appear at all. If you're writing about who consumers escalate to, this is the table.

Use it when: Reporting a medical-debt story that needs a named-entity ranking, building a healthcare-finance accountability dataset, researching the secondary market for unpaid medical bills, or sourcing a press lift-out paragraph for a wire piece.

Key findings

• 10,987 medical-related complaints were filed with the CFPB in 2024, queried via the public API on 8 May 2026.
• 70% — 7,695 of 10,987 — were about debt collection, not the underlying medical providers.
• Three credit bureaus (Experian, TransUnion, Equifax) received 2,223 of the medical complaints — 20% of the total.
• Three specialised medical-debt buyers (W&A Intermediate, Medical Data Systems, Capio Partners) drew 930 complaints between them.
• Synchrony Financial — the consumer bank operating Care Credit — was the only bank in the top 15 named defendants, with 130 complaints.
• The top 15 named companies account for 41% (4,499) of all medical-related CFPB complaints in 2024.
• 91% of medical CFPB complaints are about either debt-collection (70%) or credit-reporting (21%) of medical bills — the financial back-end, not the bedside billing.

In this article: Top 15 leaderboard · What the complaints are about · Story A: Credit bureaus · Story B: Medical-debt buyers · Story C: Synchrony Care Credit · Methodology · What the data does NOT support · Press lift-out · FAQ

Quick answer

• What this is: A 2024 audit of CFPB complaints whose narrative or issue text references medical concerns, grouped by named company. Universe: 10,987 complaints.
• The headline: 3 credit bureaus, 11 debt collectors, and Synchrony Financial's Care Credit. 41% of the year's medical complaints sit with those 15 named defendants.
• The mechanism: Medical bills route from providers to specialised collectors and debt-buyers, then to credit bureaus where consumers contest the resulting credit-report marks. Each layer generates complaints; the upstream provider doesn't.
• Most surprising finding: Three of the most-complained-about medical-debt firms — W&A Intermediate Co. LLC, Medical Data Systems Inc, and Capio Partners — are specialised debt buyers that don't have consumer-facing brand recognition. Combined complaint volume: 930.
• Main caveat: "Medical-related" is a search-term filter, not a strict CFPB product code. The 10,987 universe is heuristic; complaints that mention medical issues but are partly non-medical are included. Frame as a directional consumer-friction signal, not a precise medical-only count.

Compact examples — what 2024 medical-related complaints look like at the company level

Sources: CFPB Consumer Complaint Database aggregation by company, filtered for medical-related complaints in calendar year 2024, queried 8 May 2026 via ApifyForge's cfpb-consumer-complaints actor.

What is the medical debt collection industry?

Definition (short version): The medical debt collection industry is the chain of specialised firms — debt collectors, debt buyers, and credit bureaus — that pursue unpaid hospital and provider bills after the original creditor stops collecting directly.

The industry is structurally a three-tier pipeline. Tier one is the original creditor — hospitals, physician groups, dental practices, vet clinics — who issue the bill, attempt internal collection for 90-180 days, and then either sell the unpaid balance to a debt buyer or assign it to a collection agency. Tier two is the specialised collector or debt buyer who pursues the balance directly, sending letters, calling consumers, and eventually reporting unpaid balances to credit bureaus. Tier three is the credit bureau, which records the unpaid debt as a tradeline on the consumer's credit report and processes any disputes the consumer files.

The 2024 CFPB data captures friction at tiers two and three. Tier-one hospitals don't appear in the leaderboard because hospitals aren't directly regulated by the CFPB and aren't typically named in consumer complaints filed through the bureau's intake channels. The named-defendant ranking is downstream of the medical-billing event, not at it.

Also known as: medical debt collection, healthcare receivables, medical accounts receivable, hospital bad debt collection, medical debt buying, medical bill collection.

Top 15 medical-related complaint defendants 2024

Source: CFPB Consumer Complaint Database aggregation by company field, search-term filter "medical", date range 2024-01-01 to 2024-12-31, queried 8 May 2026 via the cfpb-consumer-complaints Apify actor in outputMode: "aggregation". Universe: 10,987 medical-related complaints. Type categorisation by manual review of each company's stated business model and CFPB filing history.

The remaining 59% spreads across thousands of smaller debt collectors, individual hospitals appearing in single-digit complaint counts, and credit-card issuers handling medical balances rolled into general consumer credit. The top-15 concentration is the story: the medical-debt collection industry — measured by consumer escalation volume — is more concentrated than the recipient-side healthcare-provider system.

Complaint composition by product

70% debt collection plus 21% credit reporting is 91% of medical CFPB complaints. The remaining 9% is medical balances rolled into other financial products — credit-card balances run up to pay hospital bills, mortgages tied to medical-bankruptcy-driven defaults, vehicle loans cross-defaulted with medical accounts. The headline is unambiguous: when consumers escalate a medical-related complaint to the federal regulator, they're almost always escalating either being chased for the bill or having that bill hit their credit report.

Story A — The credit bureau chokepoint

Experian (788) plus TransUnion (737) plus Equifax (698) equals 2,223 medical-related CFPB complaints in 2024 — 20% of the total. The mechanism: medical bills routed to debt collectors typically get reported to credit bureaus within 90-180 days of non-payment; consumers then dispute the credit-report mark with the bureau, not the original creditor. The bureau is the chokepoint, structurally, where consumers can contest a tradeline that originated upstream.

The structural overlap with the broader CFPB landscape is worth naming. The same three credit bureaus dominated the entire 2024 CFPB complaint database — together receiving 84% of all CFPB complaints per the Big 3 Credit Bureau audit published earlier in this series. In the medical sub-segment they sit at 20%, not 84%. The structural-role difference matters: in the broader database, bureaus are complained about for credit-report errors generally; in the medical segment, they're the disputed-data layer for medical-bill collection specifically. The companies are the same. The complaint mechanism is different.

The bureau dominance is structural, not corruption. Three companies hold credit files on roughly the same 200+ million credit-active US adults. Any debt that gets reported as a tradeline goes through their pipeline. The medical-debt-specific friction sits in the dispute-resolution loop — consumers asking the bureau to remove or correct a medical-debt entry that the consumer believes was mishandled by the upstream collector. That dispute mechanic generates complaint volume regardless of bureau behaviour quality on a per-case basis.

"The same three credit bureaus that received 84% of all 2024 CFPB complaints — Experian, TransUnion, Equifax — also dominate the medical sub-segment with 2,223 complaints, or 20% of the medical universe. Medical bills hit credit reports faster than nearly any other consumer-debt category, and the bureaus are the chokepoint where consumers contest those marks."

Story B — The specialised medical-debt buyers most consumers have never heard of

Three companies in the top 15 are specialised medical-debt buyers — firms whose business model is buying portfolios of unpaid medical bills from hospitals at a discount, then collecting at face value or reporting unpaid balances to credit bureaus. Combined 2024 complaint volume: 930, or 8.5% of the medical universe.

These firms are the secondary-market layer between hospitals (who write off uncollected bills at a fraction of face value) and credit bureaus (who eventually mark consumer credit reports). The business is legal. The complaint volume isn't an indictment of the model; it's a measure of consumer-facing friction it generates. W&A Intermediate's 522 complaints alone exceed the medical-related complaint volume of every individual hospital chain in the database.

The visibility gap matters. None of the three firms have consumer-facing brand recognition in the way Experian or Synchrony do. A consumer who receives a collection letter from W&A Intermediate Co., LLC for a hospital balance the consumer thought was paid by insurance has limited ability to pattern-match the company against any prior touchpoint. The consumer's own hospital didn't tell them their account was sold. The collector's letterhead is the first surface of the new commercial relationship. CFPB complaint volume is the downstream consequence of that information-asymmetric handoff.

"Three specialised medical-debt buyers — W&A Intermediate Co. LLC (522 complaints), Medical Data Systems Inc (244), and Capio Partners (164) — collectively received 930 CFPB complaints in 2024. None are household names. All are in the business of buying unpaid medical bills from hospitals at a discount and pursuing the original face value."

Story C — Synchrony Care Credit is the only bank in the top 15

Synchrony Financial sits at rank 11 with 130 medical-related CFPB complaints. It's the only consumer bank in the top 15 named defendants, sitting alongside specialised debt collectors and credit bureaus. The driver is Synchrony's Care Credit product — a deferred-interest medical credit card pitched to patients at dental offices, vet clinics, dermatology practices, and elective-surgery providers.

The deferred-interest mechanism is the recurring complaint pattern. Care Credit's promotional offers commit to "no interest if paid in full" within 6, 12, 18, or 24 months — but if even $1 of the original promotional balance remains unpaid at the deadline, the full retroactive interest at a high APR is added back to the account. Consumer complaints in the 2024 corpus describe paying down 95% or 99% of a balance, missing the deadline by a payment cycle, and being charged retroactive interest on the entire original principal. The 2013 CFPB enforcement action against CareCredit — a $34.1 million settlement on deceptive enrollment disclosures — addressed an earlier iteration of the same mechanism. The 2024 complaint volume reflects continued consumer friction with the product, not new misconduct established by enforcement.

The point-of-care sales channel matters. Care Credit applications are typically processed at the dental office or clinic front desk, with a staff member walking the patient through the application while the patient is still anchored on the cost of the procedure they came in for. Consumer complaints in the 2024 corpus repeatedly cite limited disclosure of the deferred-interest mechanism at the application moment — patients reporting they understood the promo period as "no interest, period," not "no interest if 100% paid by deadline."

"Synchrony Financial — the consumer-bank operator of Care Credit, the deferred-interest medical credit card pitched at dental and vet offices — is the only bank in the top 15 most-complained-about medical-related companies in the 2024 CFPB database. The deferred-interest mechanism is the recurring complaint pattern."

What a CFPB medical-related complaint record looks like

A single CFPB complaint record returns a structured object with the fields below. The "medical-related" classification used in this audit is a search-term match against the consumer narrative or issue text — not a separate CFPB product code.

{
  "complaint_id": "11346216",
  "date_received": "2024-08-15",
  "product": "Debt collection",
  "sub_product": "Medical debt",
  "issue": "Attempts to collect debt not owed",
  "sub_issue": "Debt was result of identity theft",
  "company": "W&A Intermediate Co., LLC",
  "state": "TX",
  "consumer_complaint_narrative": "I received a collection letter for a hospital balance I never owed. The hospital had billed my insurance and the balance was settled. The collector continues to report this debt on my credit report despite multiple disputes...",
  "company_response": "Closed with explanation",
  "timely_response": "Yes",
  "submitted_via": "Web"
}

Two things to note about the record shape. First, sub_product does include Medical debt as a recognised sub-category — but a complaint can be classified under generic Debt collection with the medical context only appearing in the narrative text, which is why this audit uses a narrative search-term filter rather than a sub-product filter. Second, consumer_complaint_narrative is consumer-supplied free text, with personally identifying information redacted by the CFPB before publication. The narrative is the only place that carries the medical context for many complaints filed under generic product codes.

Methodology

• Tool: ApifyForge's cfpb-consumer-complaints Apify actor in outputMode: "aggregation" mode, with aggregateBy set to company for the leaderboard and product for the composition table.
• Underlying API: The actor wraps the CFPB Consumer Complaint Database public API, which is the same source primary journalists can query directly without the actor.
• Search filter: searchTerm: "medical" against the 2024 calendar-year complaint corpus. The filter matches against the consumer narrative, issue text, and sub-issue fields.
• Date range: 2024-01-01 through 2024-12-31, by date_received.
• Universe size: 10,987 complaints matched the medical-related filter. All percentage shares in this post are computed against that universe.
• Type categorisation: Each company in the top 15 was classified as credit bureau, specialised medical-debt buyer, specialised medical-debt collector, generalist debt collector, or consumer bank by manual review of the company's public filings, CFPB filing history, and stated business model. The categorisation is editorial; the underlying complaint counts are direct from the CFPB API.
• Reproduction: Any of the leaderboard rows can be reproduced by querying the CFPB public API directly with the same filters. The actor wraps the API for users who want batched aggregation without writing the API client themselves; the underlying numbers are publicly verifiable.

What the data does NOT support

These are the questions journalists should ask before quoting any single number from this post in a news lead. The CFPB-data-source caveats from the broader 2024 CFPB Big 3 audit all apply here too, plus several specific to the medical segment.

• "Medical-related" is a search-term filter, not a strict product filter. A complaint qualifies for the 10,987 universe if its narrative or issue text mentions medical concerns. Some complaints flagged as medical may be tangentially-medical — for example, a debt collector pursuing a portfolio that includes both medical and non-medical balances, where the consumer's narrative names a single medical bill among others. The 10,987 figure is a heuristic universe, not a precise count of medical-only complaints. Frame as a directional consumer-friction signal rather than a precise medical-only census.
• The credit-bureau dominance is structural. Experian, TransUnion, and Equifax appearing at the top of the medical leaderboard is the same structural credit-report-dispute mechanic that produces their 84% share in the broader CFPB database. It is not evidence of bureau wrongdoing on medical specifically. Coverage that quotes the medical-segment bureau number should disclose the structural overlap and ideally link to the broader bureau-dominance dataset rather than re-litigate it.
• Specialised medical-debt buyers operate legally. W&A Intermediate, Medical Data Systems, and Capio Partners run a legal business model — buying unpaid medical bills at a discount and collecting at face value. Their CFPB complaint volumes don't establish illegality; they establish consumer-friction volume. Frame accordingly. Each firm responds to the CFPB process and provides company responses on the public docket.
• Synchrony Care Credit's deferred-interest pattern is a known regulatory subject. The 2013 CFPB enforcement action against CareCredit settled for $34.1 million on deceptive-enrollment disclosures. The 2024 complaint volume of 130 reflects continued consumer friction with the deferred-interest mechanism — not a new wave of misconduct established by enforcement. Coverage should distinguish current complaint volume from past enforcement findings.
• Hospitals don't appear in the data. The CFPB does not directly regulate hospitals, and the medical-leaderboard's absence of hospital-system entries does not mean hospitals don't drive medical-debt friction. It means consumer complaints about hospital billing tend to route through state attorneys general, state hospital-regulator complaint channels, or no-surprises-act dispute-resolution under HHS — not through the CFPB. The medical-debt story upstream of collection is real and has been extensively reported by KFF Health News and others; it just doesn't surface here.
• The 70% debt-collection share is high but not unique to medical. Across all CFPB complaints in 2024, debt collection is also a top product category, and the medical-segment 70% is elevated relative to other categories but not anomalous in its concentration on debt collection rather than the underlying creditor.
• PE-owned hospital chains are not visible in this data. This audit was originally framed as a PE-emergency-room story (PE-owned ER staffing firms — Envision, TeamHealth, USACS — and PE-owned hospital chains — Steward, Prospect, Lifepoint — driving aggressive billing). The CFPB data doesn't surface those companies because hospitals don't sit in the CFPB's regulated-entity list. The PE story is real and well-covered (see Wall Street Journal's 2024 series and the Steward Health Care Chapter 11 filing) but it manifests at a layer the CFPB complaint database doesn't index.

Implementation checklist for journalists working from this dataset

1. Cross-reference any single named-defendant figure against the CFPB public API using the same filter (searchTerm=medical, date_received_min=2024-01-01, date_received_max=2024-12-31).
2. Pull the company-specific complaint detail records before publishing — narrative-level review surfaces the modal complaint pattern per defendant, which strengthens any single-company story.
3. For credit bureau coverage, link to the broader 2024 CFPB Big 3 dominance audit and disclose the structural overlap rather than implying medical-segment bureau friction is uniquely high.
4. For Care Credit / Synchrony coverage, link to the 2013 CFPB enforcement action and characterise current complaint volume as continued friction with the deferred-interest mechanism, not new misconduct.
5. For specialised medical-debt buyer coverage, verify each company's current operating status, parent-company affiliation, and any state-level enforcement before naming it. The CFPB profile pages (linked in Story B) show the per-company filing history.
6. Cite both the CFPB public API and the cfpb-consumer-complaints Apify actor used to produce the aggregations — the API is the primary source; the actor is the reproducibility layer.

Common misconceptions

"The most-complained-about companies in medical-debt are hospitals." Not in the CFPB database. Hospitals don't appear in the top 15. The CFPB doesn't directly regulate hospitals, and consumer complaints about hospital billing typically route through state attorneys general or HHS no-surprises-act channels, not the CFPB.

"Specialised medical-debt buyers like W&A Intermediate or Capio Partners are illegal operations." The business model — buying unpaid medical bills from hospitals at a discount and collecting at face value — is legal under federal law and state-level licensing regimes. CFPB complaint volume measures consumer-facing friction, not legality.

"The credit bureaus are uniquely problematic for medical debt." The bureau dominance in the medical segment (20% of complaints) is the same structural credit-report-dispute mechanic that produces their 84% share across the entire 2024 CFPB database. Medical-segment bureau friction is not unique; it's the medical instance of a broader pattern documented in the Big 3 Credit Bureau audit.

"Synchrony Care Credit's 130 complaints in 2024 represent new regulatory exposure." The deferred-interest mechanism behind most Care Credit complaints has been a regulatory subject since the 2013 $34.1 million CFPB settlement. Current volume reflects continued friction post-settlement, not establishment of new misconduct.

"PE-owned hospital chains drive the named-defendant ranking." They don't appear at all. Hospitals — PE-owned or otherwise — aren't CFPB-regulated entities, so they don't surface in this dataset regardless of upstream billing behaviour. The PE-medical-debt story is real and well-covered elsewhere; it just doesn't manifest here.

Key facts about 2024 CFPB medical-debt-collection complaints

• 10,987 medical-related complaints were filed with the CFPB in calendar year 2024.
• 70% of those complaints — 7,695 — were filed against debt collectors rather than the original medical providers.
• Three credit bureaus (Experian, TransUnion, Equifax) collectively received 2,223 medical-related complaints, or 20% of the universe.
• Three specialised medical-debt buyers (W&A Intermediate, Medical Data Systems, Capio Partners) collectively received 930 complaints, or 8.5% of the universe.
• Synchrony Financial — the operator of Care Credit — was the only consumer bank in the top 15 named defendants.
• The top 15 named companies account for 41% of all medical-related CFPB complaints filed in 2024.
• 91% of medical CFPB complaints concern either debt collection (70%) or credit reporting (21%).
• Hospitals don't appear in the top 15, because the CFPB doesn't directly regulate hospital billing.

When you need this dataset

You probably need this dataset if:

• You're writing a healthcare-finance accountability piece that requires a named-defendant ranking with verifiable consumer-complaint volume.
• You're reporting on a specific medical-debt collector and need to contextualise their CFPB complaint volume against peers.
• You're building a research-integrity or due-diligence dataset that flags exposure to high-complaint medical-debt firms.
• You're covering Care Credit, Synchrony's deferred-interest medical card, or post-settlement consumer-friction trends.
• You're sourcing a press lift-out paragraph for a wire piece on medical-debt collection.

You probably don't need this dataset if:

• You're researching upstream hospital billing — those complaints route through state regulators, not the CFPB.
• You need a precise medical-only complaint count — the search-term filter is heuristic, not a strict product code.
• You need PE-owned hospital chain accountability data — those entities don't appear in CFPB filings.
• You're looking for enforcement actions — complaint volume is not the same as regulatory finding or settlement.

Limitations

• Universe is heuristic, not precise. The 10,987 figure uses a narrative search-term match for "medical." Some complaints in the universe are tangentially medical; some genuinely-medical complaints filed without that keyword are missed. Treat the universe as directional.
• Volume is not a measure of behaviour quality. A specialised medical-debt buyer with 100,000 active accounts and 522 complaints has a different per-account rate than a smaller firm with 10,000 accounts and 50 complaints. The leaderboard ranks by raw volume, not by complaint rate per active account, because account-base disclosures aren't consistently published for the named firms.
• Subsidiary aggregation isn't normalised. The CFPB company field is consumer-reported. A complaint against a subsidiary of one of the named firms may appear under the subsidiary name rather than the parent. The leaderboard uses the CFPB's reported company name without parent-company reconciliation.
• 2024 totals can shift after publication. The CFPB removes some complaints that fail validation (duplicate filings, invalid product codes). The 10,987 figure is the database state as of 8 May 2026.
• Hospitals are absent because they aren't CFPB-regulated. The bureau's intake process focuses on financial products and services regulated under federal consumer-finance law. Hospital billing complaints tend to route through state attorneys general, HHS no-surprises-act dispute resolution, and state hospital-regulator channels. Their absence from this dataset is a regulatory-architecture artefact, not evidence of low hospital-billing friction.

Glossary

Medical-debt buyer — A specialised firm that purchases unpaid medical bills from hospitals or providers at a discount, then attempts collection at face value or sells the unpaid balance further down the chain.

Credit bureau — A consumer-reporting agency (Experian, TransUnion, Equifax in the US) that maintains credit files on consumers and processes disputes against tradelines reported by creditors and collectors.

Tradeline — An entry on a consumer's credit report representing a single account — original credit, collection account, or charged-off debt — with a balance, status, and reporting history.

Care Credit — A deferred-interest medical credit card operated by Synchrony Financial, marketed at dental, vet, and elective-surgery providers; the deferred-interest mechanism is the dominant complaint pattern.

Deferred-interest financing — A credit product where promotional-period interest is waived if the balance is paid in full by the deadline, but charged retroactively on the entire original balance if any amount remains unpaid at the deadline.

Sub-product code — The CFPB classification system's secondary tag below product — used here is Medical debt under Debt collection, though many medical-related complaints are filed under generic Debt collection with medical context only in the narrative.

Broader applicability

The patterns documented in this audit aren't unique to the medical segment. They generalise to any consumer-debt category where the original creditor and the collecting party are different entities:

1. Visibility asymmetry between consumer and collector. Consumers don't typically know when their debt is sold. The first surface of the new commercial relationship is the collector's letter, which means complaint friction concentrates at the collector layer regardless of upstream creditor behaviour.
2. Credit-bureau dispute mechanics as the chokepoint. Wherever debt is reported as a tradeline, the bureau is where consumers contest it. That dispute-resolution surface generates complaint volume that scales with the volume of disputed tradelines, not with bureau behaviour quality on a per-case basis.
3. Specialised debt-buyer concentration. Markets for charged-off consumer debt — medical, credit-card, student-loan, telecom — converge on a small number of specialised buyers per category. The buyer-concentration pattern this audit documents in medical generalises to other consumer-debt types.
4. Point-of-care credit products. Care Credit's deferred-interest pattern at dental and vet offices has structural parallels in furniture-store financing, jewellery-store financing, and elective-procedure financing more broadly. Wherever a credit application is processed at the point of sale alongside the underlying purchase decision, the disclosure-quality complaint pattern recurs.
5. Regulatory-architecture artefacts. Categories of consumer-debt friction that don't surface in CFPB complaint data are not absent — they're routed through other regulators. Awareness of which complaint channel matches which industry segment matters more than treating CFPB volume as a comprehensive measure of any one industry.

Press lift-out for journalists

A copy-paste-ready version of the headline finding for newsroom use:

"A 2026 ApifyForge analysis of the CFPB Consumer Complaint Database for 2024 found 10,987 complaints contain medical-related issues, with 70% (7,695) about debt collection rather than the underlying medical providers. The top 15 most-complained-about companies — three credit bureaus (Experian 788, TransUnion 737, Equifax 698), eleven debt collectors, and Synchrony Financial's Care Credit medical-financing product — accounted for 41% of all medical-related complaints. Three specialised medical-debt buyers — W&A Intermediate Co. LLC (522), Medical Data Systems Inc (244), and Capio Partners (164) — drew 930 complaints between them despite operating with limited public visibility."

Source for citation: ApifyForge, "3 Credit Bureaus, 11 Debt Collectors, and Care Credit: 41% of 2024 Medical CFPB Complaints," 8 May 2026. Underlying data: CFPB Consumer Complaint Database, aggregated via the public API on 8 May 2026 using ApifyForge's cfpb-consumer-complaints Apify actor.

Embeddable visuals

Chart 1 — Top 15 most-complained-about medical-related companies, 2024

Horizontal bar chart, sorted descending. The top three bars (Experian, TransUnion, Equifax) cluster around 700-800 complaints. Bar four (W&A Intermediate) sits at 522 — visibly lower than the top three but distinctly higher than rank five onward. Bars five through fifteen taper from 244 (Medical Data Systems) down to 107 (I.C. System). Colour-code by defendant type: credit bureaus in one accent colour, specialised medical-debt buyers in a second, generalist collectors in a neutral colour, Synchrony Financial in a fourth. Y-axis: company name. X-axis: 2024 medical-related complaints. Source line: "CFPB Consumer Complaint Database, 2024." Dark-mode chart. Landscape orientation, 16:9 aspect ratio, 1200x675 pixels.

Chart 2 — Medical CFPB complaints by product category, 2024

Pie chart. Slices: "Debt collection" 70.0%, "Credit reporting" 21.3%, "Credit card" 2.7%, "Checking or savings account" 2.0%, "Mortgage" 1.3%, "Other lending" 2.7%. The 70%/21% pair takes 91% of the chart and should be visually dominant. Source line: "CFPB Consumer Complaint Database, medical-related complaints, 2024." Dark-mode chart. Landscape orientation, 16:9 aspect ratio, 1200x675 pixels.

Chart 3 — Specialised medical-debt buyers vs generalist collectors vs credit bureaus, 2024

Stacked horizontal bar chart with three segments on a single bar: credit bureaus (2,223 complaints, 20% of universe), specialised medical-debt buyers (W&A + Medical Data Systems + Capio Partners = 930, 8.5%), all other named top-15 entries (1,346, 12.2%). The remaining 6,488 complaints (59%) sit outside the top 15 and can be shown as a fourth segment labelled "All other companies (combined)." The visual point: the named-defendant concentration is real, but the long tail is also significant. Source line: "CFPB Consumer Complaint Database, medical-related complaints, 2024." Dark-mode chart. Landscape orientation, 16:9 aspect ratio, 1200x675 pixels.

Frequently asked questions

Why don't hospitals appear in the most-complained-about medical-debt companies list?

The CFPB doesn't directly regulate hospitals, so consumer complaints about hospital billing typically route through state attorneys general, state hospital-regulator complaint channels, or HHS no-surprises-act dispute resolution rather than the CFPB. The CFPB intake process is built for federally-regulated consumer-finance entities — banks, credit bureaus, debt collectors, debt buyers, lenders. Hospital-billing complaints exist; they just don't surface in the CFPB database.

Are the specialised medical-debt buyers in the top 15 doing anything illegal?

No. W&A Intermediate Co. LLC, Medical Data Systems Inc, and Capio Partners run a legal business model — buying unpaid medical bills from hospitals at a discount and collecting at face value, under federal Fair Debt Collection Practices Act compliance and state-level debt-collector licensing. CFPB complaint volume measures consumer-facing friction, not legality. Coverage should frame the 930-complaint figure as a friction signal, not an indictment.

How does this dataset relate to the broader 2024 CFPB Big 3 Credit Bureau audit?

It's a sub-segment of the same database. The broader 2024 CFPB audit covered the entire 2.73 million-complaint universe and showed Experian, TransUnion, and Equifax received 84% of all complaints. The medical-segment audit shows the same three bureaus at 20% of the medical universe — a structural-role-different position. In the broader database the bureaus are complained about for credit-report errors generally; here they're the dispute-resolution layer for medical-bill collection specifically.

Why is Synchrony Financial the only bank in the top 15?

Synchrony operates Care Credit, a deferred-interest medical credit card pitched at dental offices, vet clinics, and elective-surgery providers. It's the only major consumer bank with a product specifically designed for the medical-financing market. Other banks (Chase, Capital One, Wells Fargo) appear in the broader CFPB database but not in the medical sub-segment because their consumer products don't carry medical-specific narrative volume.

Can I reproduce these numbers myself?

Yes. The full dataset is queryable directly from the CFPB Consumer Complaint Database public API using a date filter (2024-01-01 to 2024-12-31) and search term (medical). The aggregations in this post were produced by ApifyForge's cfpb-consumer-complaints Apify actor in outputMode: "aggregation" mode, which wraps the same public API; both routes produce identical numbers.

Is the 2013 CareCredit settlement relevant to current complaint volume?

It's contextually relevant. The 2013 CFPB enforcement action against CareCredit settled for $34.1 million on deceptive-enrollment disclosures. The 2024 complaint volume of 130 reflects continued consumer friction with the deferred-interest mechanism — not new misconduct established by enforcement. Coverage should distinguish current complaint volume from past enforcement findings.

How does the medical CFPB picture compare with other 2024 backlink-bait audits in this series?

The data follows a pattern that runs across the audit series: a small group of named entities accounts for a disproportionate share of the friction. In the Big 3 Credit Bureaus audit, three companies took 84% of all CFPB complaints. In the 2024 academic retractions audit, five publishers carried 73% of the year's retractions. In this medical audit, 15 named companies carry 41% of the medical-related complaint friction. The structure repeats; the named entities are different.

Related backlink-bait series posts

This is post #8 in the ApifyForge backlink-bait series — public-data audits with named-entity rankings designed for journalist citation. The other posts:

• #1 — Defense contractor lobbying ROI 2024
• #2 — FDA 510(k) shortcut vs PMA 2024 audit
• #3 — Big 3 Credit Bureaus: 84% of all 2024 CFPB complaints
• #4 — Tech podcast cemetery 2026
• #5 — SEC insider sales 2024 leaderboard
• #6 — SaaS pricing time machine 2020 to 2026
• #7 — 2024 academic retractions publisher leaderboard

Ryan Clinton publishes Apify actors and MCP servers as ryanclinton and builds developer tools at ApifyForge. The 2024 medical-related CFPB complaint aggregations in this post were produced via the cfpb-consumer-complaints Apify actor's outputMode: "aggregation" mode against the public CFPB Consumer Complaint Database API.

Last updated: May 2026

This guide focuses on the 2024 CFPB Consumer Complaint Database for medical-related complaints, but the same named-entity ranking patterns apply broadly to any consumer-debt category where the original creditor and the collecting party are different entities — credit-card debt, student-loan debt, telecom debt, vehicle-loan debt all show similar concentration of consumer-facing friction at the collector and credit-bureau layers.